Selected research
Industry Growth & Trends
Global Pet Whole Blood and Blood Components Industry Growth and Trends Forecast to 2032
Market perspective
The global Pet Whole Blood and Blood Components market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pet Whole Blood and Blood Components include Thermo Fisher Scientific, Moregate BioTech, Bovogen Biologicals (ANZCO Foods Healthcare), Pel-Freez, LLC, HemoStat Laboratories, CellSera Australia (Auckland BioSciences), Animal Technologies, Serana Europe and Lake Immunogenics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pet Whole Blood and Blood Components market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pet Whole Blood and Blood Components market size, estimates, and forecasts are presented in terms of sales volume (kL) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Whole Blood and Blood Components market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Whole Blood and Blood Components.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pet Whole Blood and Blood Components market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pet Whole Blood and Blood Components Market by Company
Thermo Fisher Scientific
Moregate BioTech
Bovogen Biologicals (ANZCO Foods Healthcare)
Pel-Freez, LLC
HemoStat Laboratories
CellSera Australia (Auckland BioSciences)
Animal Technologies
Serana Europe
Lake Immunogenics
MoreCare. Inc.
Nanjing BioChannel Biotechnology Co., Ltd
Pet Whole Blood and Blood Components Segment by Type
Canine
Feline
Bovine
Sheep
Others
Pet Whole Blood and Blood Components Segment by Application
Veterinary Hospital
Clinic
Other
Pet Whole Blood and Blood Components Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Whole Blood and Blood Components market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Whole Blood and Blood Components and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Whole Blood and Blood Components.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Whole Blood and Blood Components manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pet Whole Blood and Blood Components in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Canine
- Feline
- Bovine
- Sheep
- Others
Applications
- Veterinary Hospital
- Clinic
- Other
Companies covered
- Thermo Fisher Scientific
- Moregate BioTech
- Bovogen Biologicals (ANZCO Foods Healthcare)
- Pel-Freez, LLC
- HemoStat Laboratories
- CellSera Australia (Auckland BioSciences)
- Animal Technologies
- Serana Europe
- Lake Immunogenics
- MoreCare. Inc.
- Nanjing BioChannel Biotechnology Co., Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pet Whole Blood and Blood Components Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pet Whole Blood and Blood Components Sales Estimates and Forecasts (2021-2032)
- 1.3 Pet Whole Blood and Blood Components Market by Type
- 1.3.1 Canine
- 1.3.2 Feline
- 1.3.3 Bovine
- 1.3.4 Sheep
- 1.3.5 Others
- 1.4 Global Pet Whole Blood and Blood Components Market Size by Type
- 1.4.1 Global Pet Whole Blood and Blood Components Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pet Whole Blood and Blood Components Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pet Whole Blood and Blood Components Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pet Whole Blood and Blood Components Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pet Whole Blood and Blood Components Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pet Whole Blood and Blood Components Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pet Whole Blood and Blood Components Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pet Whole Blood and Blood Components Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pet Whole Blood and Blood Components Industry Trends
- 2.2 Pet Whole Blood and Blood Components Industry Drivers
- 2.3 Pet Whole Blood and Blood Components Industry Opportunities and Challenges
- 2.4 Pet Whole Blood and Blood Components Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pet Whole Blood and Blood Components Revenue (2021-2026)
- 3.2 Global Top Players by Pet Whole Blood and Blood Components Sales (2021-2026)
- 3.3 Global Top Players by Pet Whole Blood and Blood Components Price (2021-2026)
- 3.4 Global Pet Whole Blood and Blood Components Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pet Whole Blood and Blood Components Major Company Production Sites & Headquarters
- 3.6 Global Pet Whole Blood and Blood Components Company, Product Type & Application
- 3.7 Global Pet Whole Blood and Blood Components Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pet Whole Blood and Blood Components Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pet Whole Blood and Blood Components Players Market Share by Revenue in 2025
- 3.8.3 2025 Pet Whole Blood and Blood Components Tier 1, Tier 2, and Tier 3
4 Pet Whole Blood and Blood Components Regional Status and Outlook
- 4.1 Global Pet Whole Blood and Blood Components Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pet Whole Blood and Blood Components Historic Market Size by Region
- 4.2.1 Global Pet Whole Blood and Blood Components Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pet Whole Blood and Blood Components Sales in Value by Region (2021-2026)
- 4.2.3 Global Pet Whole Blood and Blood Components Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pet Whole Blood and Blood Components Forecasted Market Size by Region
- 4.3.1 Global Pet Whole Blood and Blood Components Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pet Whole Blood and Blood Components Sales in Value by Region (2027-2032)
- 4.3.3 Global Pet Whole Blood and Blood Components Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pet Whole Blood and Blood Components by Application
- 5.1 Pet Whole Blood and Blood Components Market by Application
- 5.1.1 Veterinary Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Pet Whole Blood and Blood Components Market Size by Application
- 5.2.1 Global Pet Whole Blood and Blood Components Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pet Whole Blood and Blood Components Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pet Whole Blood and Blood Components Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pet Whole Blood and Blood Components Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pet Whole Blood and Blood Components Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pet Whole Blood and Blood Components Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pet Whole Blood and Blood Components Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pet Whole Blood and Blood Components Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Pet Whole Blood and Blood Components Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Moregate BioTech
- 6.2.1 Moregate BioTech Company Information
- 6.2.2 Moregate BioTech Business Overview
- 6.2.3 Moregate BioTech Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Moregate BioTech Pet Whole Blood and Blood Components Product Portfolio
- 6.2.5 Moregate BioTech Recent Developments
- 6.3 Bovogen Biologicals (ANZCO Foods Healthcare)
- 6.3.1 Bovogen Biologicals (ANZCO Foods Healthcare) Company Information
- 6.3.2 Bovogen Biologicals (ANZCO Foods Healthcare) Business Overview
- 6.3.3 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Product Portfolio
- 6.3.5 Bovogen Biologicals (ANZCO Foods Healthcare) Recent Developments
- 6.4 Pel-Freez, LLC
- 6.4.1 Pel-Freez, LLC Company Information
- 6.4.2 Pel-Freez, LLC Business Overview
- 6.4.3 Pel-Freez, LLC Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pel-Freez, LLC Pet Whole Blood and Blood Components Product Portfolio
- 6.4.5 Pel-Freez, LLC Recent Developments
- 6.5 HemoStat Laboratories
- 6.5.1 HemoStat Laboratories Company Information
- 6.5.2 HemoStat Laboratories Business Overview
- 6.5.3 HemoStat Laboratories Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 HemoStat Laboratories Pet Whole Blood and Blood Components Product Portfolio
- 6.5.5 HemoStat Laboratories Recent Developments
- 6.6 CellSera Australia (Auckland BioSciences)
- 6.6.1 CellSera Australia (Auckland BioSciences) Company Information
- 6.6.2 CellSera Australia (Auckland BioSciences) Business Overview
- 6.6.3 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Product Portfolio
- 6.6.5 CellSera Australia (Auckland BioSciences) Recent Developments
- 6.7 Animal Technologies
- 6.7.1 Animal Technologies Company Information
- 6.7.2 Animal Technologies Business Overview
- 6.7.3 Animal Technologies Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Animal Technologies Pet Whole Blood and Blood Components Product Portfolio
- 6.7.5 Animal Technologies Recent Developments
- 6.8 Serana Europe
- 6.8.1 Serana Europe Company Information
- 6.8.2 Serana Europe Business Overview
- 6.8.3 Serana Europe Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Serana Europe Pet Whole Blood and Blood Components Product Portfolio
- 6.8.5 Serana Europe Recent Developments
- 6.9 Lake Immunogenics
- 6.9.1 Lake Immunogenics Company Information
- 6.9.2 Lake Immunogenics Business Overview
- 6.9.3 Lake Immunogenics Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Lake Immunogenics Pet Whole Blood and Blood Components Product Portfolio
- 6.9.5 Lake Immunogenics Recent Developments
- 6.10 MoreCare. Inc.
- 6.10.1 MoreCare. Inc. Company Information
- 6.10.2 MoreCare. Inc. Business Overview
- 6.10.3 MoreCare. Inc. Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 MoreCare. Inc. Pet Whole Blood and Blood Components Product Portfolio
- 6.10.5 MoreCare. Inc. Recent Developments
- 6.11 Nanjing BioChannel Biotechnology Co., Ltd
- 6.11.1 Nanjing BioChannel Biotechnology Co., Ltd Company Information
- 6.11.2 Nanjing BioChannel Biotechnology Co., Ltd Business Overview
- 6.11.3 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Product Portfolio
- 6.11.5 Nanjing BioChannel Biotechnology Co., Ltd Recent Developments
7 North America by Country
- 7.1 North America Pet Whole Blood and Blood Components Sales by Country
- 7.1.1 North America Pet Whole Blood and Blood Components Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pet Whole Blood and Blood Components Sales by Country (2021-2026)
- 7.1.3 North America Pet Whole Blood and Blood Components Sales Forecast by Country (2027-2032)
- 7.2 North America Pet Whole Blood and Blood Components Market Size by Country
- 7.2.1 North America Pet Whole Blood and Blood Components Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pet Whole Blood and Blood Components Market Size by Country (2021-2026)
- 7.2.3 North America Pet Whole Blood and Blood Components Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pet Whole Blood and Blood Components Sales by Country
- 8.1.1 Europe Pet Whole Blood and Blood Components Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pet Whole Blood and Blood Components Sales by Country (2021-2026)
- 8.1.3 Europe Pet Whole Blood and Blood Components Sales Forecast by Country (2027-2032)
- 8.2 Europe Pet Whole Blood and Blood Components Market Size by Country
- 8.2.1 Europe Pet Whole Blood and Blood Components Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pet Whole Blood and Blood Components Market Size by Country (2021-2026)
- 8.2.3 Europe Pet Whole Blood and Blood Components Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pet Whole Blood and Blood Components Sales by Country
- 9.1.1 Asia-Pacific Pet Whole Blood and Blood Components Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pet Whole Blood and Blood Components Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pet Whole Blood and Blood Components Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pet Whole Blood and Blood Components Market Size by Country
- 9.2.1 Asia-Pacific Pet Whole Blood and Blood Components Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pet Whole Blood and Blood Components Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pet Whole Blood and Blood Components Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pet Whole Blood and Blood Components Sales by Country
- 10.1.1 South America Pet Whole Blood and Blood Components Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pet Whole Blood and Blood Components Sales by Country (2021-2026)
- 10.1.3 South America Pet Whole Blood and Blood Components Sales Forecast by Country (2027-2032)
- 10.2 South America Pet Whole Blood and Blood Components Market Size by Country
- 10.2.1 South America Pet Whole Blood and Blood Components Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pet Whole Blood and Blood Components Market Size by Country (2021-2026)
- 10.2.3 South America Pet Whole Blood and Blood Components Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pet Whole Blood and Blood Components Sales by Country
- 11.1.1 Middle East and Africa Pet Whole Blood and Blood Components Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pet Whole Blood and Blood Components Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pet Whole Blood and Blood Components Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pet Whole Blood and Blood Components Market Size by Country
- 11.2.1 Middle East and Africa Pet Whole Blood and Blood Components Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pet Whole Blood and Blood Components Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pet Whole Blood and Blood Components Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pet Whole Blood and Blood Components Value Chain Analysis
- 12.1.1 Pet Whole Blood and Blood Components Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pet Whole Blood and Blood Components Production Mode & Process
- 12.2 Pet Whole Blood and Blood Components Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pet Whole Blood and Blood Components Distributors
- 12.2.3 Pet Whole Blood and Blood Components Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst